Skip to search boxSkip to navigationSkip to main content

Relationship of dog- and cat-specific IgE and IgG4 levels to allergic symptoms on pet exposure

  • Mary Burnett(corresponding author)
    ,
  • Ganesa Wegienka
    ,
  • Suzanne Havstad
    ,
  • Haejin Kim
    ,
  • Christine Cole Johnson
    ,
  • Dennis Ownby
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Background: Environmental allergens may induce the generation of allergen-specific IgE (sIgE) and IgG4 (sIgG4). Some studies report an association of sIgG4 to protection against allergic symptoms after exposure to the relevant allergen. Objective: We examined the relationship of dog and cat sIgE and sIgG4 levels to self-reported allergic symptoms on pet contact. Methods: Participants 18 years of age in the Detroit Childhood Allergy Study cohort were asked whether they experienced symptoms on exposure to cats and dogs. Serum was assayed for cat and dog sIgE and sIgG4. Geometric means, ratios of cat and dog sIgE, sIgG4, and ratios of sIgG4/sIgE were compared between symptomatic and asymptomatic teens with the use of Wilcoxon rank sum tests. Ratios of sIgG4/sIgE, adjusted for presence of sIgE (≥ 0.35 kU/mL), were analyzed with logistic regression. Results: Data on 500 participants were analyzed. Compared with asymptomatic teens, teens symptomatic with cat exposure had higher cat sIgE, sIgG4, and lower ratio of sIgG4/sIgE. Teens symptomatic after dog exposure had higher dog sIgE levels and lower sIgG4/sIgE, but similar levels of sIgG4 compared with asymptomatic participants. Increasing cat and dog sIgG4/sIgE ratios were associated with a lower likelihood of reporting allergic symptoms (cat: adjusted odds ratio, 0.8; 95% CI, 0.6-0.9; dog: adjusted odds ratio, 0.8; 95% CI, 0.7-1.0). Conclusion: sIgG4 levels to cat and dog allergens correlate with lower rates of pet-induced allergic symptoms when interpreted in the context of concomitant sIgE. However, sIgG4 appears to have little utility as an isolated marker to indicate that pet exposure will be well tolerated.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 350-353 (4 pages)

Journal (Volume, Issue Number)

Journal of Allergy and Clinical Immunology: In Practice (Volume 1, Issue 4)

Publication milestones

  • Published - 07/2013

Publication status

Published - 07/2013

ISSN

2213-2198

Publication IDs

  • Scopus: 84879828641
  • PubMed: 24565540

Publication metrics

Metrics

Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
0.38
SciVal
Author count
7
SciVal
citations
12
SciVal
Paper percentile
70

PlumX, opens in new tab

Captures
29
Citation count
18

Funding Details

Supported by the Fund for Henry Ford Hospital and National Institutes of Allergy and Infectious Diseases grant R01AI051598 . Conflicts of interest: M. Burnett, G. Wegienka, H. Kim, C. Cole Johnson, and D. Ownby have received research support from the National Institutes of Health. E. Zoratti has received research support from the National Institute of Allergy and Infectious Diseases. S. Havstad declares that she has no relevant conflicts.
FundersFunding numbers
Fund for Henry Ford Hospital
-
NIH
-
NIAID
R56AI050681, R01AI051598